NeuroStar® TMS Therapy
FDA-cleared, non-medication depression treatment
(855) 940-4867
Still struggling with depression after trying antidepressants and talk therapy? Greenbrook Mental Wellness Centers Glen Burnie is a trusted provider of innovative treatment options for individuals with depression, including NeuroStar® Transcranial Magnetic Stimulation (TMS) therapy and SPRAVATO® (esketamine) nasal spray. Most major insurance plans cover our treatments. Schedule a no-cost consultation with a member of our Care Team to find out if these therapies are right for you.
info@greenbrooktms.com
(855) 940-4867
1600 Crain Highway S.
Suite 602
Glen Burnie, MD 21061
Holiday weekend, and extended hours by appointment
Located in Crain Towers on Rt. 3, just off Rt. 100, and 1 mile from Baltimore Washington Medical Center. Head south on Route 3, and the towers will be on your first sharp right turn following Crabtown and across the street from Hardees. Parking is open. Enter through the front and take the elevators to the 6th floor. Suite 602 is directly on your lefthand side.
At Greenbrook our dedicated Care Team will support you every step of the way—from insurance coordination to scheduling and beyond. Schedule a no-cost consultation today, and we'll help you find a depression treatment that's right for you. We're here to answer any questions you have.
During your consultation, you will meet with a Consult Coordinator to learn about the treatment process, and our Care Team will start the insurance paperwork if needed. Next, you will meet with a Greenbrook-affiliated licensed mental health provider for an evaluation, which includes detailed questions about your history and symptoms. If the Greenbrook provider has determined that you're a candidate for SPRAVATO® or NeuroStar TMS therapy and you're ready to move forward, they will create your individualized treatment plan. Then, you're ready to start treatment at Greenbrook!
More about NeuroStar TMS therapy
What is NeuroStar TMS therapy?
NeuroStar TMS (Transcranial Magnetic Stimulation) goes right to the source of depression – your brain. It is a non-invasive, non-drug treatment that uses focused magnetic pulses to “wake up” those areas and help your brain work the way it should. It’s like physical therapy for your brain.1,2
What is the average NeuroStar TMS treatment plan?
Greenbrook NeuroStar TMS treatment plans typically include 30 to 36 sessions over a six- to nine-week period, depending on the patient’s diagnosis, insurance requirements, and individualized care plan. Each session is as little as 19 minutes, and you can resume normal activities immediately after treatment.
More about SPRAVATO® (esketamine) nasal spray treatment
What is SPRAVATO®?
SPRAVATO® is an FDA-approved nasal spray. It is a prescription medicine used:
What is a typical SPRAVATO® treatment plan?
Treatment is provided under the direct supervision and monitoring of trained medical professionals for at least two hours. After your two-hour monitoring, you may feel groggy and woozy. You will need to avoid hazardous activities for the remainder of the day, including operating a motor vehicle.
A typical treatment plan consists of:
Treatment plans may vary depending on clinical conditions.
1. Post A, et al. (2001). J Psychiatric Research, 35:193-215.
2. Liston C, Chen AC, Zebley BD, et al. (2014). Biol Psychiatry, 75(7);517-526.
<p class="rteBlock">Maryland</p>
<p class="rteBlock">Glen Burnie</p>
Please provide the requested information on the form and Greenbrook Mental Wellness Centers will contact you shortly. All information will be kept strictly confidential. We do not sell or share your information.
*If you are a referring Physician interested in contacting Greenbrook Mental Wellness Centers about a current patient, please use this form.
Greenbrook supports an accessible internet. If you have any questions about our accessibility features, please contact us at
(855) 940-4867 or info@greenbrooktms.com.
NeuroStar Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
NeuroStar Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).
Important Safety Information
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
Visit neurostar.com for full safety and prescribing information.
Important Safety Information
What is the most important information I should know about SPRAVATO®?
SPRAVATO® can cause serious side effects, including:
Do not take SPRAVATO® if you:
If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO®.
Before you take SPRAVATO®, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Taking SPRAVATO® with certain medicine may cause side effects.
Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicine. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.
How will I take SPRAVATO®?
What should I avoid while taking SPRAVATO®?
Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO®. Do not take part in these activities until the next day following a restful sleep. See “What is the most important information I should know about SPRAVATO®?”
What are the possible side effects of SPRAVATO®?
SPRAVATO® may cause serious side effects including:
See “What is the most important information I should know about SPRAVATO®?”
Increased blood pressure. SPRAVATO® can cause a temporary increase in your blood pressure that may last for about 4 hours after taking a dose. Your healthcare provider will check your blood pressure before taking SPRAVATO® and for at least 2 hours after you take SPRAVATO®. Tell your healthcare provider right away if you get chest pain, shortness of breath, sudden severe headache, change in vision, or seizures after taking SPRAVATO®.
Problems with thinking clearly. Tell your healthcare provider if you have problems thinking or remembering.
Bladder problems. Tell your healthcare provider if you develop trouble urinating, such as a frequent or urgent need to urinate, pain when urinating, or urinating frequently at night.
The most common side effects of SPRAVATO® include:
If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day.
These are not all the possible side effects of SPRAVATO®.
Call your doctor for medical advice about side effects. You may report side effects to Johnson & Johnson at 1-800-526-7736, or to the FDA at 1-800-FDA-1088.
What is SPRAVATO® (esketamine) CIII nasal spray?
SPRAVATO® is a prescription medicine used:
SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe or effective as an anesthetic medicine.
It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®.
It is not known if SPRAVATO® is safe and effective in children.
Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO® and discuss any questions you may have with your healthcare provider.
All Rights Reserved | Greenbrook TMS NeuroHealth Centers.